Epitopea
PrivateLast Round
VC Round
Oct 24, 2024
Total Funding Raised
$14.26M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Epitopea is a biotechnology company developing off-the-shelf RNA-based cancer immunotherapies that target a novel class of tumor-specific antigens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epitopea Comparables
Compare Epitopea with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enara Bio | 84% | |
| Hervolution Therapeutics | 81% | |
| Cartography Biosciences | 80% | |
Epitopea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 24, 2024 | ||||
| Grant | Sep 12, 2024 | ||||
| Seed | Apr 25, 2022 |
Epitopea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Investissement Québec | VC Round |
| CTI Life Sciences Fund | VC Round, Seed |
| IRICoR | VC Round |
| Fonds de solidarité FTQ | VC Round, Seed |
| Consortium Québécois sur la découverte du médicament | Grant |
| Advent Life Sciences | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Susana Banerjee appointed Chief Investigator for OVACT trial.
- Apr 13, 2026
Lisa Butterfield appointed to the Scientific Advisory Board.
Epitopea Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epitopea's valuation, stock price, and market status.